ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
0,03
0,00
(0,00%)
Geschlossen 08 Juni 10:00PM

Gemina Laboratories Ltd (GLAB) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,03
( - )
Gebot
0,03
Fragen
0,085
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,03
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
$ 8.000
Ausgegebene Aktien
76.570.907
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,77
Gewinn pro Aktie (EPS)
-0,04
Erlöse (LTM)
10,88k
Nettogewinn (LTM)
-2,93M

Über Gemina Laboratories Ltd

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It ... Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Burnaby, Canada
Gegründet
2026
Gemina Laboratories Ltd is listed in the Healthcare sector of the Canadian Securities Exchange with ticker GLAB. The last closing price for Gemina Laboratories was $0,03. Over the last year, Gemina Laboratories shares have traded in a share price range of $ 0,00 to $ 0,00.

Gemina Laboratories currently has 76.570.907 shares in issue. The market capitalisation of Gemina Laboratories is $2,30 million. Gemina Laboratories has a price to earnings ratio (PE ratio) of -0.77.

GLAB Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GLAB - Frequently Asked Questions (FAQ)

What is the current Gemina Laboratories Ltd share price?
The current share price of Gemina Laboratories Ltd is $ 0,03
How many Gemina Laboratories Ltd shares are in issue?
Gemina Laboratories Ltd has 76.570.907 shares in issue
What is the market cap of Gemina Laboratories Ltd?
The market capitalisation of Gemina Laboratories Ltd is CAD 2,3M
What is the 1 year trading range for Gemina Laboratories Ltd share price?
Gemina Laboratories Ltd has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Gemina Laboratories Ltd?
The price to earnings ratio of Gemina Laboratories Ltd is -0,77
What is the cash to sales ratio of Gemina Laboratories Ltd?
The cash to sales ratio of Gemina Laboratories Ltd is 211,17
What is the registered address of Gemina Laboratories Ltd?
The registered address for Gemina Laboratories Ltd is 3600 Gilmore Way, Burnaby, British Columbia, V5G 4W8
What is the Gemina Laboratories Ltd website address?
The website address for Gemina Laboratories Ltd is www.geminalabs.com
Which industry sector does Gemina Laboratories Ltd operate in?
Gemina Laboratories Ltd operates in the Biotechnology & Life Sciences sector

GLAB Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen